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The thalassemias are a heterogeneous group of genetic disorders characterized by
impaired hemoglobin production. Hemoglobin is made up of 2 alpha and 2 beta
globin chains; mutations in either the alpha or beta globin genes result in reduced
or compromised production of the globin chains of hemoglobin.1 Most thalassemias
are inherited in a Mendelian recessive fashion, and the severity of the disease varies widely; heterozygotes are usually asymptomatic while homozygotes or compound heterozygotes are more severely afflicted.2 Defects in 1 β allele manifest as
β-thalassemia trait, which is a mild variation of the disease. Where both β globin alleles
are affected, the resulting condition, thalassemia major, is a severe, life-threatening
disease requiring regular transfusions and medical support to aid normal growth and
development of the individual.1
Hemoglobinopathies represent the most common single gene disorder in the
world.3 Worldwide, 5% of the population is suffering from a variant of thalassemia;
however, many are asymptomatic, silent carriers. Thalassemia is widely distributed,
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Purpose: Health care initiatives focusing on prenatal testing and premarital genetic screening
aiming to reduce the incidence of β-thalassemia have emerged during the last decade. In Palestine,
4% of the population are known thalassemia carriers with new cases continuing to appear despite
the availability of prenatal testing. This study aims to identify factors that influence the decision
to retain or abort fetuses affected by β-thalassemia in Palestine.
Methods: Convenience sampling was used to select 32 women (72 fetuses) who were at risk
of having a baby with β-thalassemia. A questionnaire on prenatal testing, test results, pregnancy
outcomes, and factors influencing the decision to terminate the pregnancy were used for this
cross-sectional study. The data were analyzed using SPSS version 17.
Results: Among the fetuses screened, 36 (50%) were thalassemia carriers and 20 (28%) had
β-thalassemia; 17 (85%) affected fetuses were aborted. Religious beliefs were the most cited
reason for opposing abortion while prior experience with β-thalassemia patients and awareness
programs promoted abortions. Mothers who opted to retain an affected fetus had modest
educational attainment. Higher educational level was significantly associated with the decision
to abort an affected fetus (p,0.05).
Conclusion: A religious consensus is needed on the abortion of fetuses affected by
β-thalassemia. Improving female education and increasing awareness on thalassemia could
help reduce the incidence of β-thalassemia in Palestine and around the world.
Keywords: abortion, Islam, fetus, awareness
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with the highest prevalence in malaria-endemic tropical and
subtropical regions, affecting almost 4.4 per 10,000 live
births globally.4
Since the late 1960s, regular transfusion regimens have
been promoted for thalassemia major patients to maintain
close to normal hemoglobin levels. The use of long-term
iron chelation with desferrioxamine prevents iron overload
but this treatment is expensive and requires parenteral
administration.5
Bone marrow transplantation is the only possible cure for
thalassemia, if a human leukocyte antigen (HLA)-matched
donor is available.6 Since thalassemia is predominant in
the lower socioeconomic realms of the world, the cost of
treating thalassemia is prohibitive to the clear majority of
those afflicted even if a donor is available. The annual cost
of treating 15,000 thalassemia patients in Iran is estimated
to be $200 million.7 Preimplantation diagnosis by the polymerase chain reaction is considered a viable option to limit
the number of new cases of thalassemia.8

Thalassemia in Palestine
A survey carried out in 1996 by the World Health Organization in collaboration with The Thalassemia Patients’ Friends
Society (TPFS) revealed a 4% prevalence of thalassemia carriers in Palestine – ~1,500,000 carriers.9 The relatively high
prevalence of thalassemia gene carriers could mean a higher
number of thalassemia patients in the future. The Ministry
of Health (MOH) of Palestine registered 816 thalassemia
patients in 2009; 76% of these patients were born out of
consanguineous marriages.9 In the Gaza strip, 0.02% of the
population are known to have β-thalassemia, with IVS-I-110
being the most frequent mutation in the Gaza strip.10 The
average life expectancy of a thalassemia patient in Palestine
is merely 15 years with many thalassemia patients suffering
from iron overload – iron levels exceeding 1,000 mg/dL.9
The use of unscreened blood in Palestine increases the risk
of blood-borne infections in these patients. Inability to
maintain normal healthy relationships, fear of the outcome
of the disease, and prohibitive costs contribute to further
psychological and social stress in patients. National Medical
Services are unable to meet the cost of almost $15,000 per
thalassemia patient per year.9 Health care initiatives focusing on prenatal testing and premarital genetic screening
aiming to reduce the incidence of thalassemia have emerged
during the last decade.11
A premarital screening program for β-thalassemia carriers
aimed to reduce the incidence of thalassemia by discouraging
marriage between known thalassemia carriers. For carriers
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married before the year 2000, prenatal diagnoses through
chorionic villus sampling (CVS) and amniocentesis were
introduced to supplement the screening program.11 Amniocentesis for prenatal diagnosis of chromosomal anomalies
is performed at 16–20 weeks of gestation.12 On the other
hand, CVS is performed earlier, typically between the 10th
and 12th weeks of gestation, allowing for earlier prenatal
diagnosis.13
According to the TPFS, there has been a drastic reduction
in the incidence of thalassemia during the years 2000–2007
following the establishment of the screening program
(Figure 1); yet new cases continue to emerge.9
A study conducted in 2005 in the West bank and Gaza
concluded that all families with fetuses testing positive for
β-thalassemia decided to abort their fetus.14 Nonetheless,
there are no published studies that explain the persistence
of appearance of new cases in the Palestinian territories
despite prenatal testing. There is limited awareness on
prenatal diagnosis in Palestine, and there are no laws
to guide parents toward making decisions regarding an
affected fetus.15

Prenatal diagnosis of β-thalassemia

Prenatal diagnosis of β-thalassemia is rapidly gaining importance in reducing the incidence of β-thalassemia. Research
has confirmed the significance of offering prenatal diagnosis
to women/couples at risk of having a fetus with clinically
significant thalassemia or other hemoglobinopathies. 16
Since its inception in the 1980s, CVS has gained popularity
as a means of rapid prenatal diagnosis in early pregnancy,
hence rendering it is less emotionally and physically taxing
than second-trimester procedures like amniocentesis. 17
First-trimester diagnosis of β-thalassemia allows more
options for the affected couples, particularly in countries
where abortions are opposed due to religious and cultural
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Figure 1 Number of new cases from year 2000 to 2007 in Palestine.
Note: Data from Karmi.9
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sanctions. Availability of fetal diagnosis gives carrier couples
the opportunity to consider procreating, with the possibility
of giving birth to a healthy child.14
In a study in India, where 29% of the fetuses included in
the study were found to have β-thalassemia, parents opted
for termination of the pregnancy regardless of the gestational
age. This denoted the importance of prenatal diagnosis of
affected children in developing countries.16

Thalassemia and Islam
Many Islamic scholars have ruled that it is permissible to
abort a fetus with serious medical conditions before the
“occurrence of soul-breathing” (“ensoulment”) at 120 days
of gestation. This is based on the Prophetic statement:
The creation of a person takes place in the mother’s belly
for forty days in the form of a seed, then he is a tiny clinging

Continuing emergence of β-thalassemia

A study on β-thalassemia major patients of Pakistani
origin in the UK revealed that Pakistani women’s attitudes
toward prenatal diagnosis and termination of pregnancy
were influenced by a multitude of factors and religion
alone should not be taken as a reflection of their attitudes
regarding abortion.18
This study aims to identify the influencing factors that
explain why some parents in Palestine choose to give birth
to a fetus affected by β-thalassemia despite the financial and
psychological implications associated with the disease.

Material and methods
Study design and settings
A cross-sectional analytical study was conducted in 5 districts
of the Palestinian Authority, namely, Nablus, Tulkarm, Jenin,
Ramallah, and Qalqilya.

thing for a like period, then there is sent to him the angel
who blows the breath of life into him.18

In September 1984, the High Council for Islamic Legal
Opinions in Kuwait, and in 1990 the Islamic Jurisprudence
Council in Saudi Arabia declared that abortions before
120 days of gestation were permissible only if it was certain
that the fetus would be born with an incurable disease or
deformity.19 Also, in Pakistan Islamic scholars permit termination of pregnancy within 120 days of pregnancy if medical
conditions compel it. Nevertheless, in a study in Pakistan,
6 out of 53 fetuses were diagnosed with thalassemia, yet the
option to abort was declined on religious grounds.20 Recent
acceptance of legal abortion in Iran in accordance with Islamic
rules has had a major influence on people’s attitude toward
prenatal diagnosis and the abortion of affected fetuses.13
In Palestine, as in many other Islamic countries, abortion
is legal only if the pregnancy is a threat to the mother’s
life or if the fetus shows anomalies incompatible with life
following delivery. β-thalassemia major is not considered an
indication for legal abortion in Palestine; therefore, the case
is referred to the religious judge (Mufti) to take a religiously
sanctioned decision.15
Islamic scholars opinions are riddled with controversy
surrounding rulings related to thalassemia.21 The main
dispute revolves around the time of “soul emergence”.
Some scholars believe that the soul emerges at 40 days
and they thus prohibit abortion beyond 40 days of gestation, while others conclude that the soul does not emerge
before 120 days of gestation making abortion religiously
acceptable before that time; this makes early diagnosis of
thalassemia crucial.21

International Journal of Women’s Health 2017:9

Study population
This study included 32 mothers who had undergone prenatal
testing. The mothers were registered at the TPFS and the
MOH. A convenience sample was obtained from the archives
of TPFS during a 3-month period, ranging from January to
March of the year 2011. The sample excluded women from
regions of Hebron and Bethlehem since TPFS did not have
a record of mothers who underwent the test in these districts.
From 2002 onwards, 53 patients were registered at TPFS,
of whom 32 mothers underwent prenatal diagnosis tests
between 2000 and 2011. Most of these mothers already had
a child affected with β-thalassemia major and thus were
advised prenatal testing for subsequent pregnancies. The
sample was comprised of carrier mothers who had married
known β-thalassemia carrier men. The sample also included
mothers who had the prenatal diagnosis test for diagnostic
purposes on referral from TPFS and MOH in Al-Maqased
Hospital between the years of 2000 and 2011. Mothers who
had prenatal diagnostic tests before 2000 or did not reside
in Palestine were excluded from the study.
The target samples were contacted via phone using
the TPFS records and recruited after obtaining informed,
voluntary consent to participate in the study.

Data collection instrument
Data were collected through questionnaires filled out by
the study researchers. The questionnaire included a brief
introduction about the study and its objectives and was
administered in Arabic. The questionnaire comprised a total
of 20 questions and was divided into 4 sections.
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Section 1: Consisted of 8 questions on social and demographic characteristics.
Section 2: Consisted of 3 questions including the parents’
family history, the current family history of thalassemia, and
the financial burden it imposes on the family.
Section 3: Included 3 questions on the prenatal test – the
year it was done and the gestational age at the time of the
test. The gestational age was stratified based on the different
religious views, permitting abortion before a specific gestational age. Test results were explored under the categories
of normal, carrier, and affected fetuses.
Section 4: Included 6 questions. The main question was
about the outcome of pregnancy after receiving the test
results. Where abortion was performed, the gestational age
at the time of abortion was asked. The family’s religious and
personal perspectives on abortion were also explored.

Ethics and informed consent
A written approval to conduct the study was obtained from
the An-Najah National University Institutional Review
Board on February 22, 2012. Another letter of approval to
conduct this study was obtained from the MOH to get access
to the thalassemia patients’ records. Informed consent was
obtained from all participants and they were assured that
confidentiality of those involved in the study would be maintained. Permission was taken to publish the data gathered in
the research.
All procedures performed in our study involving human
participants were in accordance with the ethical standards
of the institutional research committee and with the 1964
Helsinki declaration and its later amendments or comparable
ethical standards.

Data collection
A total of 32 meetings were conducted with mothers from the
targeted areas. All meetings were conducted with the cooperation of the TPFS centers, in an environment that offered
privacy and comfort. In Nablus, a contact number was left at
the TPFS center in Al Watani Hospital, and the researchers
were contacted to conduct meetings when a mother brought in
her child for a blood transfusion. In Tulkarm, Jenin, Qalqilya,
Ramallah, and Tubas centers, the TPFS team communicated
with the mothers via phone to make arrangements for them
to come for a meeting.

Data analysis
All data were entered, tabulated, and analyzed using version
17 of SPSS software. The principal investigators handled
all data themselves to maintain confidentiality. Data were
676
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presented as frequencies and cross tabulations. Chi-square
analysis was used to relate sociodemographic characteristics
and a p-value of ,0.05 was considered significant.

Results
Sociodemographic characteristics
A total of 32 mothers, aged between 22 and 44 years old, were
included in this study. Their mean age was 33.56 years and the
standard deviation was 4.032 years. According to the patient’s
records in the TPFS files, 14 out of 32 (43.8%) mothers
were from Nablus, 9 (28.1%) from Tulkarm, 4 (12.5%)
from Ramallah, 4 (12.5%) from Jenin, and 1 (3.1%) from
Qalqilya (Figure 2).
The monthly income of the families included in the
study ranged from 1,500 to 4,000 New Israeli Shekel (NIS),
with a mean of 2,334.38 NIS and standard deviation of
588.25 NIS. According to the Palestinian Central Bureau
of Statistics, 2,236 NIS was considered the poverty line for
the year 2011.22 Twenty-five families (78.1%) were below the
poverty line while only 7 families (21.9%) were above the
poverty line (Table 1).
Overall, 17 (53.1%) mothers had entered high school,
9 (28.1%) had completed elementary school, and 6 (18.8%)
had a Bachelor degree (Table 1).

Health status and perceived financial
burden
Of the participating mothers, 31 had at least one child
with thalassemia in the family. Twenty-five (80.6%) of the
31 mothers reported that their children were in good health,
4 (12.9%) said their children had recurrent illnesses, and
2 (6.5%) felt their children were in poor health (Table 2).
In total, 11 (35.5%) out of these families considered their
financial burden to be minimal and mainly due to transportation costs. Another 11 (35.5%) considered their burden
to be moderate and 7 (22.5%) felt the financial burden was
high. Only 2 (6.5%) out of 31 felt no financial burden at all.
Financial burden was based on the mothers’ perceptions.
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Figure 2 Number of participants from each district in Palestine.
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Table 1 Sociodemographic characteristics of the study sample
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Variable
Economic status of family
• Below poverty line (,2,236 NIS/month)
• Above poverty line (.2,236 NIS/month)
Mother’s education
• Elementary school
• High school
• Diploma
• Bachelor degree
Fathers education
• Elementary school
• High school
• Diploma
• Bachelor degree

n=32

%

25
7

78.1
21.9

9
17
0
6

28.1
53.1
0
18.8

9
15
1
7

28.1
46.9
3.1
21.9

Prenatal test
In total, 72 prenatal tests were carried out for the 32 participating mothers. The reason to undergo testing was preexisting thalassemia patients in the family in 60 out of 72 cases.
The other 12 tests were done on referrals from obstetricians.
The cost of the tests was partially covered by the MOH
for 55 tests out of the 72 (76.6%), while for the remaining
17 (23.6%) tests, expenses were borne by the family.
The gestational age of fetuses at the time of testing was
under 120 days in 44 (61%) cases and between 120–140 days
in the other 28 (39%) fetuses. Among the 72 fetuses tested
by DNA analysis, 16 (22.2%) were found to be normal,
36 (50%) were thalassemia carriers, and 20 (27.8%) suffered
from β-thalassemia (Figure 3).
Out of the 20 affected fetuses, 17 (70.5%) were aborted.
The decision to abort in 12 cases was due to an unwillingness
to have a child with β-thalassemia after having first-hand
experience with thalassemia patients. These parents were
familiar with the challenges associated with thalassemia. The
remaining 5 (29.5%) fetuses were aborted based on informed
decisions following thalassemia awareness programs organized by TPFS.
Table 2 Health status of affected child and perceived financial
burden
Variable

n=31

Current health condition of affected child in the family
• Good health
25
• Recurrent illness
4
• Poor health
2
Financial burden of caring for a thalassemia patient
• No burden
2
• Mild burden eg, transportation costs
11
• Moderate burden
11
• High burden
7
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Figure 3 Results of prenatal testing.

Most abortions, 11 (64.7%) out of 17 were carried out
at gestational age of ,120 days. The remaining 6 (35.3%)
fetuses were aborted between 120 and 140 days of gestation.
Interestingly, parents who decided against abortion despite
carrying affected fetuses, decided to do so even though the
gestational age was ,120 days. This finding repudiates the
relationship between gestational age at time of diagnosis and
the decision to abort the fetus.
While 85% of the affected fetuses were aborted, three
families proceeded with the pregnancy despite the test result.
Of these, two families cited religious beliefs as their reason
for refusing to abort while one family felt the desire to have a
baby surpassed the challenges that would be faced in raising
a child with thalassemia.
There was no apparent influence of the district from where
the people came and their decision regarding the outcome of
pregnancy. All families with an affected fetus belonged to a
low socioeconomic status (,2,236 NIS/month).
There was no impact of the mother’s employment
status on the outcome of pregnancy. However, the mother’s
educational level had a significant influence on her decision to keep or abort the fetus (p,0.05). All 3 mothers who
decided to keep their baby had considerably modest formal
educational. In contrast, all mothers who decided in favor
of aborting an affected fetus were more highly educated.
Those who refused abortion included 7 (58.4%) mothers with
high school education and only 5 (41.6%) out of 12 with an
undergraduate degree.
There was no obvious influence of the fathers’ occupation or educational level on the decision to keep or abort
the baby.

Relationship between the medical
condition of the affected thalassemia
family member and the outcome of
pregnancy
All the 3 families who continued with the pregnancy of
an affected fetus already had a child with thalassemia in
the family. Among the 12 families who aborted the fetus,
11 families already had a case of thalassemia in the family.
submit your manuscript | www.dovepress.com
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Thus, there was no significant relationship between the
current health status of a thalassemic child in the family and
the outcome of pregnancy.
There was no relationship between the financial burden of
having a child with thalassemia in the family and the decision
to keep or abort an affected fetus.

Religious opinion of mothers
On inquiring about the families’ religious point of view
regarding abortion, 10 (31.3%) out of 32 mothers believed
abortion was forbidden regardless of the gestational age,
20 (62.5%) mothers thought abortion was permissible under
such conditions, and 2 (6.2%) mothers remained neutral to
religious views.
Among 12 mothers who had undergone at least 1
abortion, 4 (33.3%) believed abortions were forbidden in
Islam. A total of 7 (58.3%) mothers thought abortions were
permissible in medically sanctioned conditions and 1 (8.4%)
mother remained noncommittal.

Discussion
A religious directive regarding abortion of fetuses affected
by β-thalassemia major remains elusive. The conflict of
religious opinions on the gestational age before which abortion is acceptable indicates the need for as early a diagnosis
as possible.18 A previous study done in Palestine concluded
that prenatal diagnosis should be performed before the 17th
gestational week (119 days), as this would increase the possibility of religiously accepted termination of pregnancy
of an affected fetus.14 However, in this study, we did not
find a relationship between the time of performing the test,
the gestational age, and the outcome of pregnancy. Out of
17 fetuses, 11 (64.7%) were aborted before 120 days’ of
gestational age while the other 6 fetuses (35.3%) were aborted
at 120–140 days. Contrary to indications given by other
studies, all those who decided to continue their pregnancies
despite having an affected fetus did so even though the fetus
was under 120 days of gestational age.
A previous study carried out on thalassemia major
patients of Pakistani origin in the UK revealed that attitudes
toward prenatal diagnosis and termination of pregnancy are
influenced by a multitude of factors and not religion alone.18
Our study endeavored to explore other factors, along with
religion, that could influence decisions regarding aborting an
affected fetus. We were unable to relate factors like financial
well-being, employment status, or region of residence to the
decision regarding the outcome of pregnancy. This could
be, in part, due to the limited sample size used in our study.

678

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

However, educational status of the mother had a significant
impact on her decision; all the mothers who decided to
continue with a pregnancy of an affected fetus had a very
modest educational background. In contrast, the mothers
who decided to abort the fetus were more educated than the
mothers who chose to continue with the pregnancy. A study
in Greece reinforces the general belief held by many in the
biomedical world that education and economic reforms
are critical for the success of public health campaigns
like the thalassemia awareness program. They highlighted
difficulties faced in translating scientific information to
a semiliterate audience when even literate populations
found it difficult to comprehend the complexities of genetic
mutations.23

Study limitations
The sample was a relatively small, non-probability convenience sample, taken from the TPFS records, which was not
inclusive of all patients. Some districts could not be included
in the study due to unavailability of records at the TPFS.

Conclusion
In Palestine, absence of a religious consensus on the acceptability of abortion is one of the foremost reasons behind
reluctance to abort a fetus known to have β-thalassemia.
With prevention being the only feasible way to control thalassemia, vague religious opinions will continue to compromise
efforts to reduce the incidence of β-thalassemia. A focus on
improving female education could empower women to take
informed decisions that are best suited to their lifestyles.
Therefore, we recommend that thalassemia awareness
programs should be implemented and their outreach
increased. There is a need for people in Palestine to understand what the disease entails and the financial, social, and
psychological implications of living with a child with thalassemia. Information on prenatal testing of thalassemia should
be made more accessible to all, along with advocating early
referrals for prenatal testing to give parents the option of a
religiously accepted abortion.
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